BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16998794)

  • 1. ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas.
    Jeong EG; Soung YH; Lee JW; Lee SH; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2006 Dec; 119(12):2986-7. PubMed ID: 16998794
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
    Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
    Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of UBR5 gene encoding an E3 ubiquitin ligase in common human cancers.
    Kim MS; Oh JE; Eom HS; Yoo NJ; Lee SH
    Pathology; 2010 Jan; 42(1):93-4. PubMed ID: 20025491
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of Wnt pathway gene LEF1 in common human carcinomas.
    Jeong EG; Lee SH; Yoo NJ; Lee SH
    Dig Liver Dis; 2007 Mar; 39(3):287-8. PubMed ID: 17267311
    [No Abstract]   [Full Text] [Related]  

  • 5. Young Onset Breast and Colon Cancer.
    Brandler J; Wu TT; Sweetser S
    Gastroenterology; 2017 Apr; 152(5):e12-e13. PubMed ID: 28273439
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas.
    Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Pathology; 2006 Aug; 38(4):358-9. PubMed ID: 16916729
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutational analysis of the extracellular domain of ERBB4 gene in common carcinomas.
    Kim MS; Yoo NJ; Lee SH
    Pathology; 2011 Feb; 43(2):169-70. PubMed ID: 21233683
    [No Abstract]   [Full Text] [Related]  

  • 9. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
    Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
    Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JAK2 V617F mutation in de novo acute myelogenous leukemias.
    Lee JW; Kim YG; Soung YH; Han KJ; Kim SY; Rhim HS; Min WS; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2006 Mar; 25(9):1434-6. PubMed ID: 16247455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase domain mutation of MAP2K4 is rare in gastric, colorectal and lung carcinomas.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Pathology; 2006 Jun; 38(3):263-4. PubMed ID: 16753753
    [No Abstract]   [Full Text] [Related]  

  • 12. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
    Chen HL; Gabrilovich D; Virmani A; Ratnani I; Girgis KR; Nadaf-Rahrov S; Fernandez-ViƱa M; Carbone DP
    Int J Cancer; 1996 Sep; 67(6):756-63. PubMed ID: 8824545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers.
    Park SW; Chung NG; Han JY; Eom HS; Yoo NJ; Lee SH
    APMIS; 2010 Jan; 118(1):83-4. PubMed ID: 20041876
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatic mutations of the ERBB4 kinase domain in human cancers.
    Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    Kim MS; Jeong EG; Yoo NJ; Lee SH
    Br J Cancer; 2008 May; 98(9):1533-5. PubMed ID: 18392055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers.
    Golmoghaddam H; Pezeshki AM; Ghaderi A; Doroudchi M
    Pathol Oncol Res; 2011 Sep; 17(3):669-75. PubMed ID: 21258883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and expressional analyses of MYD88 gene in common solid cancers.
    Je EM; Kim SS; Yoo NJ; Lee SH
    Tumori; 2012; 98(5):663-9. PubMed ID: 23235763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
    Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
    J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of point mutations of the Axin1 gene in colorectal cancers.
    Jin LH; Shao QJ; Luo W; Ye ZY; Li Q; Lin SC
    Int J Cancer; 2003 Dec; 107(5):696-9. PubMed ID: 14566817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.